Average Co-Inventor Count = 7.25
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Protagonist Therapeutics, Inc. (10 from 32 patents)
2. Protaganist Therapeutics, Inc. (1 from 1 patent)
11 patents:
1. 12234300 - Conjugated hepcidin mimetics
2. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
3. 11753443 - Conjugated hepcidin mimetics
4. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
5. 10787490 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
6. 10729676 - Opioid agonist peptides and uses thereof
7. 10278957 - Opioid agonist peptides and uses thereof
8. 10196424 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
9. 10035824 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
10. 10023614 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
11. 9624268 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases